Top Markets
Coin of the day
Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL
Classement en actions #37250
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Prix de l'action
$0.05137558
Dernière synchronisation: 2026-08-13
Capitalisation boursière
$1.88M
Changement (1 jour)
0.00%
Changement (1 an)
-11.66%
Pays
CA
Échange Restart Life Sciences Corp. (HEAL)

Catégorie

Ratio P/S pour Restart Life Sciences Corp. (HEAL)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Restart Life Sciences Corp., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Restart Life Sciences Corp. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
10.17 -
US
10.13 -
NL
- -
CH
- -
KR
4.74 -
BE